Melissa W Wachterman1, Corey Pilver2, Dawn Smith3, Mary Ersek4, Stuart R Lipsitz5, Nancy L Keating6. 1. Section of General Internal Medicine, VA Boston Healthcare System, Boston, Massachusetts2Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts3Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer. 2. Center for Healthcare Organization and Implementation Research, VA Boston Healthcare System, Boston, Massachusetts5Tufts Health Plan, Watertown, Massachusetts. 3. Center for Health Equity Research and Promotion, Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania. 4. Center for Health Equity Research and Promotion, Department of Veterans Affairs Medical Center, Philadelphia, Pennsylvania7University of Pennsylvania School of Nursing, Philadelphia. 5. Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts. 6. Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts8Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Abstract
IMPORTANCE: Efforts to improve end-of-life care have focused primarily on patients with cancer. High-quality end-of-life care is also critical for patients with other illnesses. OBJECTIVE: To compare patterns of end-of-life care and family-rated quality of care for patients dying with different serious illnesses. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cross-sectional study was conducted in all 146 inpatient facilities within the Veteran Affairs health system among patients who died in inpatient facilities between October 1, 2009, and September 30, 2012, with clinical diagnoses categorized as end-stage renal disease (ESRD), cancer, cardiopulmonary failure (congestive heart failure or chronic obstructive pulmonary disease), dementia, frailty, or other conditions. Data analysis was conducted from April 1, 2014, to February 10, 2016. MAIN OUTCOMES AND MEASURES: Palliative care consultations, do-not-resuscitate orders, death in inpatient hospices, death in the intensive care unit, and family-reported quality of end-of-life care. RESULTS: Among 57 753 decedents, approximately half of the patients with ESRD, cardiopulmonary failure, or frailty received palliative care consultations (adjusted proportions, 50.4%, 46.7%, and 43.7%, respectively) vs 73.5% of patients with cancer and 61.4% of patients with dementia (P < .001). Approximately one-third of patients with ESRD, cardiopulmonary failure, or frailty (adjusted proportions, 32.3%, 34.1%, and 35.2%, respectively) died in the intensive care unit, more than double the rates among patients with cancer and those with dementia (13.4% and 8.9%, respectively) (P < .001). Rates of excellent quality of end-of-life care reported by 34 005 decedents' families were similar for patients with cancer and those with dementia (adjusted proportions, 59.2% and 59.3%; P = .61), but lower for patients with ESRD, cardiopulmonary failure, or frailty (54.8%, 54.8%, and 53.7%, respectively; all P ≤ .02 vs patients with cancer). This quality advantage was mediated by palliative care consultation, setting of death, and a code status of do-not-resuscitate; adjustment for these variables rendered the association between diagnosis and overall end-of-life care quality nonsignificant. CONCLUSIONS AND RELEVANCE: Family-reported quality of end-of-life care was significantly better for patients with cancer and those with dementia than for patients with ESRD, cardiopulmonary failure, or frailty, largely owing to higher rates of palliative care consultation and do-not-resuscitate orders and fewer deaths in the intensive care unit among patients with cancer and those with dementia. Increasing access to palliative care and goals of care discussions that address code status and preferred setting of death, particularly for patients with end-organ failure and frailty, may improve the overall quality of end-of-life care for Americans dying of these illnesses.
IMPORTANCE: Efforts to improve end-of-life care have focused primarily on patients with cancer. High-quality end-of-life care is also critical for patients with other illnesses. OBJECTIVE: To compare patterns of end-of-life care and family-rated quality of care for patients dying with different serious illnesses. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cross-sectional study was conducted in all 146 inpatient facilities within the Veteran Affairs health system among patients who died in inpatient facilities between October 1, 2009, and September 30, 2012, with clinical diagnoses categorized as end-stage renal disease (ESRD), cancer, cardiopulmonary failure (congestive heart failure or chronic obstructive pulmonary disease), dementia, frailty, or other conditions. Data analysis was conducted from April 1, 2014, to February 10, 2016. MAIN OUTCOMES AND MEASURES: Palliative care consultations, do-not-resuscitate orders, death in inpatient hospices, death in the intensive care unit, and family-reported quality of end-of-life care. RESULTS: Among 57 753 decedents, approximately half of the patients with ESRD, cardiopulmonary failure, or frailty received palliative care consultations (adjusted proportions, 50.4%, 46.7%, and 43.7%, respectively) vs 73.5% of patients with cancer and 61.4% of patients with dementia (P < .001). Approximately one-third of patients with ESRD, cardiopulmonary failure, or frailty (adjusted proportions, 32.3%, 34.1%, and 35.2%, respectively) died in the intensive care unit, more than double the rates among patients with cancer and those with dementia (13.4% and 8.9%, respectively) (P < .001). Rates of excellent quality of end-of-life care reported by 34 005 decedents' families were similar for patients with cancer and those with dementia (adjusted proportions, 59.2% and 59.3%; P = .61), but lower for patients with ESRD, cardiopulmonary failure, or frailty (54.8%, 54.8%, and 53.7%, respectively; all P ≤ .02 vs patients with cancer). This quality advantage was mediated by palliative care consultation, setting of death, and a code status of do-not-resuscitate; adjustment for these variables rendered the association between diagnosis and overall end-of-life care quality nonsignificant. CONCLUSIONS AND RELEVANCE: Family-reported quality of end-of-life care was significantly better for patients with cancer and those with dementia than for patients with ESRD, cardiopulmonary failure, or frailty, largely owing to higher rates of palliative care consultation and do-not-resuscitate orders and fewer deaths in the intensive care unit among patients with cancer and those with dementia. Increasing access to palliative care and goals of care discussions that address code status and preferred setting of death, particularly for patients with end-organ failure and frailty, may improve the overall quality of end-of-life care for Americans dying of these illnesses.
Authors: Hien Lu; Emily Trancik; F Amos Bailey; Christine Ritchie; Kenneth Rosenfeld; Scott Shreve; Christian Furman; Dawn Smith; Catherine Wolff; David Casarett Journal: J Palliat Med Date: 2010-08 Impact factor: 2.947
Authors: Irene J Higginson; Ilora Finlay; Danielle M Goodwin; Alison M Cook; Kerry Hood; Adrian G K Edwards; Hannah-Rose Douglas; Charles E Norman Journal: J Pain Symptom Manage Date: 2002-02 Impact factor: 3.612
Authors: Anne M Walling; Steven M Asch; Karl A Lorenz; Carol P Roth; Tod Barry; Katherine L Kahn; Neil S Wenger Journal: Arch Intern Med Date: 2010-06-28
Authors: Rebecca L Sudore; David Casarett; Dawn Smith; Diane M Richardson; Mary Ersek Journal: J Pain Symptom Manage Date: 2014-05-02 Impact factor: 3.612
Authors: David Casarett; Amy Pickard; F Amos Bailey; Christine Ritchie; Christian Furman; Ken Rosenfeld; Scott Shreve; Zhen Chen; Judy A Shea Journal: J Am Geriatr Soc Date: 2008-01-16 Impact factor: 5.562
Authors: Annemieke Kuin; Annemie M Courtens; Luc Deliens; Myrra J F J Vernooij-Dassen; Lia van Zuylen; Barbara van der Linden; Gerrit van der Wal Journal: J Pain Symptom Manage Date: 2004-01 Impact factor: 3.612
Authors: David Casarett; Amy Pickard; F Amos Bailey; Christine Seel Ritchie; Christian Davis Furman; Ken Rosenfeld; Scott Shreve; Judy Shea Journal: J Palliat Med Date: 2008 Jan-Feb Impact factor: 2.947
Authors: Kabir O Olaniran; Shananssa G Percy; Sophia Zhao; Chantal Blais; Vicki Jackson; Mihir M Kamdar; Jeremy Goverman; Daniela Kroshinsky; Jennifer S Temel; Sagar U Nigwekar; Nwamaka D Eneanya Journal: J Pain Symptom Manage Date: 2018-11-03 Impact factor: 3.612
Authors: Andrei D Javier; Rocio Figueroa; Edward D Siew; Huzaifah Salat; Jennifer Morse; Thomas G Stewart; Rakesh Malhotra; Manisha Jhamb; Jane O Schell; Cesar Y Cardona; Cathy A Maxwell; T Alp Ikizler; Khaled Abdel-Kader Journal: Am J Kidney Dis Date: 2017-02-15 Impact factor: 8.860
Authors: Catherine R Butler; Margaret L Schwarze; Ronit Katz; Susan M Hailpern; William Kreuter; Yoshio N Hall; Maria E Montez Rath; Ann M O'Hare Journal: J Am Soc Nephrol Date: 2019-02-19 Impact factor: 10.121
Authors: Claire A Richards; Chuan-Fen Liu; Paul L Hebert; Mary Ersek; Melissa W Wachterman; Lynn F Reinke; Leslie L Taylor; Ann M O'Hare Journal: Clin J Am Soc Nephrol Date: 2019-08-29 Impact factor: 8.237
Authors: Jennifer S Scherer; Katherine Harwood; Julia L Frydman; Derek Moriyama; Abraham A Brody; Frank Modersitzki; Caroline S Blaum; Joshua Chodosh Journal: J Palliat Med Date: 2019-07-11 Impact factor: 2.947
Authors: Noelle E Carlozzi; E A Hahn; S A Frank; J S Perlmutter; N D Downing; M K McCormack; S Barton; M A Nance; S G Schilling Journal: J Neurol Date: 2017-11-15 Impact factor: 4.849
Authors: Nwamaka D Eneanya; Susan M Hailpern; Ann M O'Hare; Manjula Kurella Tamura; Ronit Katz; William Kreuter; Maria E Montez-Rath; Paul L Hebert; Yoshio N Hall Journal: Am J Kidney Dis Date: 2016-09-29 Impact factor: 8.860